Demetrios Konstas
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,183 of the $3,985 with a category attached, or 79.9%. It is spread thinly across 29 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,210 and has fallen 68.8% since, to $690 in 2024.
Across 161 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TG Therapeutics, Inc.$690
- Biogen$584
- AbbVie$411
- EMD Serono, Inc.$398
- Sanofi$270
- Novartis$220
- plus $1K from 23 others
What the payments were for
- Consulting fees$71518%
- Speaking & faculty fees$862%
- Food & beverage$3,18380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TG Therapeutics, Inc. | 2 | $690 |
| Biogen | 14 | $584 |
| AbbVie(2 entities) | 28 | $411 |
| EMD Serono, Inc. | 14 | $398 |
| Sanofi | 15 | $270 |
| Novartis | 14 | $220 |
| Amgen(2 entities) | 6 | $179 |
| Adamas Pharmaceuticals, Inc. | 7 | $142 |
| Arbor Pharmaceuticals, Inc. | 7 | $128 |
| Upsher-smith Laboratories LLC | 6 | $108 |
| Acorda Therapeutics, Inc | 4 | $86 |
| Vanda Pharmaceuticals Inc. | 4 | $77 |
| Merz North America, Inc. | 3 | $75 |
| Avanir Pharmaceuticals, Inc. | 4 | $69 |
| Genentech USA, Inc. | 3 | $64 |
| Lilly USA, LLC | 4 | $62 |
| Tanabe Pharma America, Inc. | 4 | $57 |
| UCB, Inc. | 3 | $57 |
| AstraZeneca | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Acadia Pharmaceuticals Inc | 2 | $38 |
| MDD US Operations, LLC | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Assertio Therapeutics, Inc. | 2 | $26 |
| Supernus Pharmaceuticals, Inc. | 2 | $24 |
| Lundbeck LLC | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Promius Pharma LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,985 in reported general payments places this provider in the 60th percentile of 1,434 neurology providers in Florida.
Other neurology in Tampa
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Mark CascioneTampa$1.2M
- Tuan VuTampa$1M
- Katherine StandleyTampa$735K
- Susan SteenTampa$341K
- Rossitza ChichkovaTampa$294K
- Brody HenkelTampa$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.